Skip to main content
Fig. 5 | BMC Genomics

Fig. 5

From: Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients

Fig. 5

The novel nomogram validation. a, AUC of risk signature, TMN-stage and hypoxia score in ROC analysis were calculated at 5-year survival time. b, AUC of risk signature in ROC analysis were calculated at 1-, 3- and 5-years survival time. c, Calibration curves of risk signature used for evaluating the 3- and 5- year AUC

Back to article page